Charlty Reglstration No. 800733 Company Registration No. 022296631England and Wales THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION IMPROVING LIVES 8Y SUPPOR TING PROFESSIONALS IN THE DÉLIVERY OF KIDNEYCARE & RESEARCH (A COMPANY LIMITED BY GUARANTEE) ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 UK Kidney Association AD703PHV 1910712024 COMPANIES HOUSE A11
203
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) CONTENTS Page Trustees report Independent auditorts report Statement of flnancial activities 15 Balance sheet 16 Statement of cash flows 17 Notes to the financial statements 18-30
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 The trustees. who are also directors of the charity for the purposes of the Companies Act 2006. present their report with the financial staterrents of the chanty for the year ended 31 December 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities.. Sl8t8ment of Recommended Practice applicable to Charities preparing their accounts in accordance with the Financial Reporting Standard appllcable in the UK and Republic of Ireland IFRS 1021 leffectwe 1 January 20191 and the Charities Act 2016. The financial statements have been prepared in accordance wrth the accounting policies set out in the notès to the financial statements and comply with The Renal Association's governin9 document, the Companies Act 2006 and 'Aecounting and Repo.ng by Chariiies.. Statement of Recommended Practice applicable to charrties pfepanng their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 1021" (effective 1 January 2019). OBJECTIVES AND ACTIVITIES Objectives and aims 'Improving lives by supporting professionals in the delivery of kidney care and research. The UK Kidnéy Association IUKKA) is the lèading profèssional body for the UK kidney community. We welcome members WrkIng in clinical renal caré, treating and caring for people wrth kidney disease, those working in research, or related sciences and fields and all allied healthcare professionals. We are transformlng the way kidney care and research is delivered in the UK and beyond. Our decisions have been and will continue to be guided by our values.. Placing patients at the centre of all decisions we make Efféctive rèpresentation of our membérship and their views Celebrating differences and promling equality Working in partn8rship with those who share our mission Equity of access to all services, regardless of professional group Ensuring data is accurate and published in the public domain Using data to continually drive qualrty and improvement Respecting and developing our staff Leading with kindness and compassion To achieve this, we will value and support all our members from all the professions that make us th8 UKI<A. The UKKA can only be successlul if each of the professlonal groups feel they have a valued place within rt. It is also crtscial we play our part within the kidney communtty working wf(h partner charities, both patient and professional facing, along with ststutory bodies at a national and regional level. These aims have required new structures and ways of working but are buift on firm foundations of good govemance including an active and engaged group of trustees, a patient and professional council supporting and shaping strategic decisions along wrth an experienced executive. ISN Fellowship Program The ISN Fellowship Program provides an opportunity for UK units to host trainees from the developing wortd for up to 12 months. Since 2002. the UK has hosted 30 ISN fellows based in 17 centres through the generous support ol the the ISN. Kidney Research UK and the UK Kidney Association. There is presently no ISN fellow in training.
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Strategic report Achievements and performance Meetings 3 to 7 January 2023.. Advanced Nephrology Course, held at Corpus Christi College, Oxford and online 26 to 27 January 2023.. BAPN Winter Meeting, held online 17 January 2023.. Renal Taster Day course, held online 18 to 19 March 2023-. Renal SpR Club Spring Meeting, held at Macoonald Burlington Hotel, 8imingham 3 to 4 May 2023: 8APN GRID Training Days, held at Glasgow's Royal Hospital for Children 5 to 7 June 2023. UK Kidney Week 2023, held at Intemational Convention Centre Wales. Newport 8 July 2023: Crash Course in Renal Medicine, held at Engineers House, Bristol 22 to 23 September 2023.. Renal Pharmocy Group Annual Conference, held at the Manchester Conference Centre 26 September 2023.. Acute Kidney Injury, 8 National Strategy Meeting. held atArden Hotel, Birmingham 12 to 13 October 2023.. 8APN GRID training days, held at Leeds Chlldren's Hospital Education Centre 14 to 15 October 2023.. Renal SpR ClubAutumn Meetlng, held al The Old Ship Hotel, Brighton 10 to 11 November 2023.. Paedlatrlc Nephrology Nurses GroupAnnual Conference, held at Friends House. London 13 November 2023". UK KidneyAssociation Industry Day. held at The Studio. Birmingham 17 November 2023.. Paediatrics Surgical Challenges Meeting, held at Evelina London Children's Hospital Monthly webinars and intemational ease discussions. Renal Association awards and prizes Ralne Award The Raine award is made annually to a relatively junior mèmber who has made a significant contribution to research. In 2023 this was awarded to Dr Melanie Chan. Walls Bursaries The John Walls 8ursary enables fvio members, a clinician and non-clinician, to spend short periods at other eentfes, generally OLrtside the UK, to learn new laboratory techniques or gain new clinical skills. In 2023 no awards were offered. Lockwoe Award The Lockwood Award is awarded to help membets to present work and combine this with a visit to a collaborats'ng laboratory or clinical nephrology unit overseas. In 2023 no awards were offered.
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT {CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Flnancial rèvlew Where our income came from? Our total income for 2023 was £4,746,977 (2022= £4,123,522) an increase of 15.1%. Income from charltablé 8Ctfvrtle$'. The majorrty of incoma is sourced from capitation fees which accounted lof £2,399,401 12022.. £2.197.440). Other income consists mainly of project work, sponsorship for events and other meetings (see note 4). The additional income in 2023 was from a successful UK Kidney Week and increased RaDaR project work. Income from memberships fell to a total of £163,832 {2022'. £177,484), this was due to a special induction rate for new MDT members. Income from scientific meetings increased to £383,905 12022. £223,418), this is due to delegate registrations for UK Kidney Week and other educational events. Income from donations. legacies and grants decreased to £162,14612022: £178,656). Thls reduction was due to the winding up of the Nurture project. Income from investments.. Increased to £44,36212022'. £9,533). This was due to a new investment platfomi and high interest rates. Where was It spent? Our total expenditure for 2023 was £4,621,713 (2022: £4,057,765) an increase of 13.9%. Direct costs.. We spent £624,722 in 202312022.. £275.8611 this increase was for 8 larger UK Kidney Week event. Support costs.. Management costs increased to £2,586,955 12022.. £2,277,305) as we employed new staff members and awarded our staff a fair cost of living increase. We started travelling more to meetings spending £141,069 (2022.. £86,104). Grants payable decreased to £39,703 (2022.. £89,987), thls reduction was due to a more streamlined KQIP budget excluding some clinical time. For further informatioTr please see notes 6-8. Expenditure Breakdown * St*fC¢XS • IT • ProfsSDnalCcraIYS • Meetir¥ Expuse5 • OffKeCo2s • Travel Flnanelal posltlon The UK Kidney Association had an overall surplus ft)r 2023 of £125,247 {2022'. £65,533). The association had an overall surplu5 of £36,835 (2022.. deficit of £25,309) and the UK Renal Registry had a surplus of £88,41212022'. £90,842). Atthe end of2023 totsl assets held by the UKKA were £3.748,210 {2022: £3,622,963).
Draft Financial Slatements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Reserves policy The trustees of the UK Kidney Association (UKKA) are obligated to act in the interests of tha charty and protect and safeguard the assets th care and skill and in an accountable manner. The reserves policy has been developed by the trustees to explain to the stakeholders why we hold a particular amount of reserves, to demonstrate that finances are being properly managed and provide assurance of our overall resilience and abilty to cover the winding up costs of the chanty should that become necessary. The benchmark for 2023 was to hold an average of £3.1 mllllon in reserve. All reserves are held either in short to medium term investments or as cash in hand at the bank. The reserves at 3111212023 were £3.748,21012022. £3.622.g63) which was above the ben¢hmarf(. Overall the UKKA is very secure. The reserves held are sufficient to cover 10 months Opefating costs and this should bé maintained. These rèserves held fluctuate throughout the year due lo the seasonaltty of our ineome however a minimum of one year ol staff salaries must be aayS maintained. whtch we adhered to k*r 2023. Inveslment policy The tTUStees are governed by the Trustee Act 2000 and invest to ensure the best financial retum with an acceptable level of risk and whilst sllll maintaining liquidity. All funds have a minimum credit rating of A- and have an ethical policy which excludes investment in pharmaceutical companies, tobacco companies and companies involved in the production or distribution of alcohol.
Draft Financial Statements at 13 May 2024 at 13".18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUEDI(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Organlsatlonal development and future plans Develowng Lead8rship' Developing current and fLrture UKI<A leaders via a suite of leadetship programmes Supporting national and regional leadership including national programmes Supporting all healthcare professionals who WOTk in kidney servicès by.. Optimising the care that they deliver. reducing variations and continuously improving qualrty Setting high standards and enabling comparative audit of patient care and data through guidelines and the UK Renal Registry Facilitating training and utilising Quality Improvement methodology supported by KQUIP Research.. W01ng closely with partners wtthin the UK Kidney Rèsearch Consortium and beyond Promoting and aiding research to reduce the burden of kidney disease and its impact on patients Investigating and evaluating seDiices Optimising the use of available real-worfd data to facilitate research Worlrforce.. Monitoring the current and future workforce requirements Engaging in shaping the future workforce Educatin9 and developing the future workforce in response to technology and other changes working wrth statutory bodies to shape curnculum as well as delivering our own Courses such as; UK Kidney Week ANC Webinars and other annual conferences for differing professional membership groups Edu¢ation.' Provision and faciif(ation of education to deliver the best possible care for p80ple wrth kidney disease Assisting wrth undergraduate and postgraduate training through seminars and webinars on latest development, UK Kidney Week, Advanced Nephrology Courses and e-Leaming modules Quality Improvement & Assurance.. Create and support leadership wlthln renal seDiices by.. Enabling leaders to shape policy for kidney care services both locally and nationally Influencing kidney caTe nationally and internationally Working wrth colleagues and partners to level up kidney care Providing optimal and sustainable kidney care Implementing digrtal soluts'ons and empowering people living with kidney dlsease to access them Shawng Serwces.. Working wrth local commissioning seTvice5 and national policy makers to shape service speclflcations Working wrth regional commissioning to ensure high standards of care Campaigning nationally and locally with partners to raise awareness of kidney disease and the services that prevent and treat it structure. governance and management Governing document The charrty is controlled by its governing document, a deed of trust, and constitutes a limrted company, limited by guarantee, as defined by the Companies Act 2006. The UK KidneyAssociation is a company limited by guarantee by rts Memorandum and Articles ofAssociation, revised in November 2020. It is registered as a charity wrth the Charty Commisslon.
Draft Financlal Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Key management vemuneration The Key Management Personnel ofthe Charty conslsts ofthe Chief Executs've Officer and Head of Operations. Vrfhere such indNiduals or those closely connected with them are remunerated by the Charrty, their pay is set by a standard salary-band matrix. Related parti¢• None of the trustees receive remuneration or other benefrts from their work with the charity. As per the amendment in the articles. the payment of reasonable and proper fees to the employer of the President is now permrtted. No payments to a president have been made to date. Related party transactlons have been disclosed in note 20. Recruitment and appointment of new trustees The Trustees of the Association are appointed in a general meeting and each individual appointment shall be for terrn in office as follows.. os•tion Prewdent x2 pointed b lected position (ballot f all memb•rsl eTm ole hair of the TN8lee8. ceIl slrntegic adership of the As60ebalton, Chairthe IM>ard f trustee8, UKKA Council and Profe88ional un¢ll. Ill nomially serve for five yearn in otal: one as PresMlent-Elecl, Ilowed by hvo orthreè year• •• r•8ld•nt, lollowed by tsvo or on• rther y¢ar8 as Past l¥esident. PtEBident ee PRstdent ee Pre8Klent ssists the Prestdent in Caying out hwJher uties and TrBponBibilittes. Chwlrn Goveman¢e nd Nomin•lion8 CommJtt•e. ee Presldent halr of tr Clinlcal Affalrn &>ard, wthich ¢ rdlnate8 the jolnt ltIOnS of the.. Clintcal erviee8 Commttle•', Clinical Practice utdelino8 Commltteè", Paknent Infonnallon mmitlee,. dneY Patsent Salety Commlttt• nd Ihe Suslalnable K¢dney Care Committee, hair ofthe Academic Affairs Board. whieh co- rdinales thè lolnl furKlions of the.. Internalional ommittee, Education and Tralning Commmee. e8earch Commlttee, Renal Sclenti618 mmittee and the Rare Dlsease Commrtl•¢. embership enquiries, genernl erquiries, mmunicat)n with the membetship, ptannl I meetings. Morflnate• UKKA wn8e8 to nsurtalions. ccourrts, rtraCt6. budgeting. Chalrn the Finance and Risk Committee. I Paediath"c Q)mmittee. Prestdent Elect lin1 Fwent x ee fvedent leded position (ballot lall members) e¢ Prtt4dent Ill r#)rn)alty 8eNe for thr¢e yea nd a maxlmum of lour yearn. demic Ifice Preltdent lected positton (ballot f all m¢mbern) Ill rnnnalty serve for three yea nd a maximum of four y¢ar6. Honorary Se¢rel•ry ppoinled by th tees Ill nOMllY serve frrthree year¥ nd a maximum of foul yearn. onor•ry Trea8uTer ppointed by the rustee8 leded posilion Ibaliol f all paediatfle mberB ppointed by Irustees Ill nomalty 8er¥e forthree yearn nd 8 maximum offour ears I ngrm?IW seNe for a maximum of hree yearn. ent ofthe 6Fth5h ocialion loi Paedialric Ne hrolo 8APN oTrmember Ie 11 nonnat seNe forthree years nd a maxbmum of six ears 11 nomMIty serye forthree yearB nd a maxtmum of four years ember ol the Flnance and Risk Committee nd GovÈmar¢e and NomInatlo Committee. oles and lilles lo be appolnted by the tsustees pointed member rLSStees PPC•inted by Inlee$
Draft Financial Statements at 13 May 2024 at 13".18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Induction and training of new trustees Newly elected members are advised of their responsibilities as directors and trustees via a job description. They have a period of hand-over wrth their predecessor before formally taking up the role. Risk Management Thetrustees have a duty to id8ntfy and reviewthe risks to which the Charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. The Finance and Risk Committee meet quarterly to review any risks, to ensure our systems are robust and to report on this risk to the trustee board. Good governance is imbedded in our organistation's culture and structure which allows us to react swiftly when necessary. Organlsatlonal structure Founded in 1950, the UK Kidney Associalion Is led by th8 8oard of Trustees who work closely with appointed officers and members of the UKKA Council. The board oftrustees meets regularfy to dlrect the affairs ofthe Charity and consult representatives trom other related organisations. The Finance & Risk and Governance & Nomination Committees consider their areas of focus in great detail and report recommendations and risks to the Board of Trustees. Development and management of specific clinical and academic activities 15 delegated to sub- committees who report their proceedings lo the Clinical orAcademic Affairs Commrttees. Commltt•es and oth•r bodles The Clinical Affairs 803rd coordinates the activities of the following committees.. ommittee Name linical Services Commrttee lintcal Practice Guidelines Committee Paknent Infomiation Commrttee Patient Safety Commrttee hair Dr Mane Condon r Mark Devonald r Yincent Tse r Katy Jones and Ms aren Jenkins r Suren ana asundaram ustainable Kidney Care Committee The Academic Affairs Board coordinates the activth'es of the following committees.. Committee Name Intemational Commrtiee Rare Disease5 Committee Education and Trainin Commrttee hair Prof Sunil Bhandan Prof Dann Gale Prof Debasish Bane ee Public Benefrt statement The trustees ensure that all actwities and future plans are in line with the Renal Association's aims and that these tske into account the Charities Commission's guidance on public benefrt. The trustees confirm thatthey have complied with the duty in section 17151 ofthe Charities Act 2011 to have regard to the Charty Commission's general guidance on public benefit, 'Charrties and Public Benefif. The charitable purposes of the Assoclation are set out in its objectives on page 1.
Draft FSnancial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 REFERENCE AND ADMINISTRATIVE DETAILS Reglstered Company number 02229883 (England and Wales) Reglstered Charty number 800733 Regl8tered offic• 8randon House Building 20a1, Southme8d Road, Filton, Bristol, BS34 7RR
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2023 Trustees President President MDT Past President Prof Paul Cockwell Ms Clare Modidge Dr Sharlene Greenwood (R8signed'August 2023) Dr Katie Vinen Prof Timothy Bowèn (Appointèd Sept8mb8r 2023) Prof Claire Sharpe (Previously) Honorary Secretary ProfAlan Salama Co-Ac8demic Vice President Prof John Sayer (Appolnt8d S6ptemb8r 2023) Prof Neil Sheerin (Pr&viously) Co-Academic Vice President Dr Kathrine Parker (Appointed September 2023) Prof Helen Hurst (Previously) Prof Jame5 Burton (Appointed September 2023) Dr Katie Vinen (Prgviously) Ms Llsa Ancliffe (Appantad August 2023) Ms Karen Jenkins (Pr8viously) Dr Jan Dudley Mr David Sifver Ms Heather Lawrence (Resigned February 2024) Professor of Nephrology Consultant Pharmacist Consultant Physiotherapist President Elect Honorary Treasurer Consultant Nephrologist Prolessor of Matrix 8 Molecular Biology Professor of Nephrology Professor of Nephrology Professor of Nephrology Professor of Nephrology Pharrnacist Consultant Nurse Co£linical Vice President Professor of Nephrology Consultant Nephrologist Co£linical Viee President Occupatlonal Therapist Consultant Nurse BAPN President Non-member Truslee Non-member Trustee Consultsnt Paediatric Nephrologist Head of European Investment Banking Chair of the London Ambulance Service The Company Oirectors ruSte8S met formally fourtimes in 2023 on.. 31 March, 4 June, 29 September and 15 December 2023. They were addrtionally in close contact throughout the year, by regular email, telephone communications and scheduled fortnightly Trustee meetings. Auditors Haines Watts (Western) Ltd, Bath House, 6-8 Bath Street, Bristol, BS16HL The auditors will be proposed for re-appointrnent atthe forthcoming Annual General Meeting Accountants Evans & Partners Ltd, 9 Bank Road, Klngswood, Bristol, BS15 8LS The accountsnts will be proposed for re-appointment at the forthcoming Annual Genergl Meeting Bankers Bank of Scotland Metro Bank Solicttors Blake Morgan, Bradley Cour( Park Place. Cardiff, CF10 3DR
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 310ECEMBER 2023 Statement of Trustees responsibilities The trustees {who are also the directors of The Renal Association for the purposes of company lawl are responsible for preparing the Report ol the Trustees and the financial statements in accordance wrth applicable law and Unrted Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 "The Financial Reportin9 Standard applicable in the UK and Republic of Ireland" Company law requires the trustees to prepare financial statèments for each financial year which give a true and fair view of the state of affairs of the charrtable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for th8t period. In preparing those financial statements, the trustees are required to se18ct suttable accounting policies and then apply them consistently.. observe the methods and principles in the Charity SORP., make judgements and estimates that are reasonable and prudent; state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements,. prepare the financial statements on the going concern basls unléss It Is In8ppropri8te to presume that the charitsble company wlll continue in buslness. The tfustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial posrtion of the charrtable company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the ¢haritsble company and hence for tsking reasonable steps for the prevention and detection of fraud and other Irregularities. In so lar as the trustees are aware.. there is no relevant audit information of which the charitable company's audltors are unaware,. and the trustees have taken all steps that they ought to have takèn to make themselves aware of any relevant audtl information and to establish that the audrtors are aware ol that inftsrnalion. This report has been prepared in accordance wrth the speci81 provisions of Part 15 of Companies Act 2006 relating to small companies. Report of the t directors, on lo s, incorporating 8 Strategic report, approved by order of the board of trustees, as the company L+ and signed on the board's behalf by.. Professor T Bow•n 10-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Oplnion We have audrted the financial ststements of The Renal Association (the 'chafrtable eompany'l for the year ended 31 December 2023 which comprise the Statement of Financial Activities, the Balance Sheet. the Cash Flow Statement and notes to the financial statements, including a summary of significant accounts'ng policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards {Unrted Klngdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland,. In our opinion, the financial statements.. give a true and fair view of the state of the charrtable Company's affair5 as at 31 December 2023 and of rts incomin9 resources and application of resources, including rts income and expenditure, for the year then ended- have been properly prepared in accordance wrth United Kingdom Generally Accepted Accounting Practice. including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland,; and have been prepared in aecordance wrth the requirements ofthe Companies Act 2006. Basis for oplnion We conductèd our audrt in accordance with International Standards on Auditing (UK) IISAS (UKI) and applicable law. Our responsibilities under those standards are further described in the Audrtors, responsibilities lor the audrt ol the finaneial statemènts section of our report. We are independent of the charitable company in accordance wrth the ethical requirements that are relevant to our audit of the financi81 statements in the UK, including the FRC'S Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Concluslons relatin9 to golng concern In auditing the ffinancial statements, we have concluded that the trustees. use of the going concem basis of accounting in the preparation of the financial stalements is appropriate. 8ased on the work we have performed. we have not Identified any material uncertainties relating to events or conditions that. individually or collectively. may cast significant doubt on the charitable CoMpanS abilty to continue as a going concem for a period of at least bNelve months from when the financial statements are authorised for issue. Our responsibilrties and the responsibilities of the trustees wrth respect to going concern are described in the relevant sections of Ihls report. Other Informatlon The trustees are responsible for thè othèr information. Thè other information comprises thè information included in the Annual Report. other than the financial statements and our Report of the IndependentAuditors thereon. OUT opinion on the financi81 statements does not cover the other information and, except to the extent otherwise explicrtly stated in our report, we do not express any fomi of assurance conclusion thereon. In connection wrth our audrt of the financial ststements, our responsibility is to read the other infomation and. in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appear5 to be materially misstated. If we identify such material IncoTTrsistencies or apparent material misstatements. we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other infornation, we are required to report that fact. We have nothing to report in thi5 regard. 11
Draft Financlal Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Opinions on other matters prescrlbed by the Companies Act 2006 In our opinion. based on the work undertaken in the course of our audit". the information given in the Report of the TTUStees for the financial year for which the financi81 statements are prepared is consistent with the finanoial staterngnts., and the Report of the Trustees has been prepared in accordance wrth applicable legal requirements. Matter$ on which we are required to report by ¢xceptlon In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audrt, we have not identified material misstatements in the Report of the Trustees. We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you rf, in our opinion.. adequate accounting records have not been kept or returns adequate for our audrt have not been received from branches not visited by us.. or the financial 5tstements are not in agreementwith the accounting records and retums., or certain disclosures of trustees, remuneration specified by law are not made., or we have not received all the infom8tion and explanations we require for our audrt., or the trustees were not entitled to take advantage of the small companles exemption from the requiremènt to prepare a Strateglc Report or in preparing the Report olthe Trustee3. Responslbllltles of trustees As explained more fvlly in the Trustees, Responsibilities Statement the trustees (who are also the directors of the charitable company for the purposes of company lawl are fesponsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation ol financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible frjr assesslng the charitable CompanS abilrty to continue as a going eoncem. disclosing. as applicable, matteTS related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charrtable company or to cease operations. or have no realistic artemative but to do so. 12-
Draft Financial Statements at 13 May 2024 at 13."18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BYGUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION Our responslbilities for the audit of the financial statements Our objectives are to obtain reasonable assurance about whether the financial ststements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not 8 guarantee that an audit conducted in accordance with ISAS IUKI will aayS detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individualty or in the aggregate. they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non4ompliance wrth laws and regulations. We design procedures in line with our responsibilities outlined above, to detect material misstatements in respect of irregularities, including fraud. We obtained an understanding of the legal and regulatory framework applicable to the charrtable company. including those areas that could reasonably be expected to have a material effect on the financial statements. The most slgnrficant were identrfied as The Companies Act 2006, UK GAAP {FRS1021, The Charrties SORP (FRS102) and The Charities Act 2011. We considered the extent of compliance with those laws and regulations as part of our procedures on the related financial statements. Our audrt procedures included: Making enquiri8s of management in respect to the susceptibilty and susplcion of fraud: Obtaining an understanding of the internal control structure., Closely examining significant unusual transactions outside the ch8rot8ble company's normal activrties., Substantive testing on journal entries for any signs ol manipulation,. Detailed review of accounting estimates,. Agreeing a sample of employee's details to payrolllHR records and contracts., Substantively testing the recognition and completeness ofthe charitable company's income streams., and Testing the allocats'on of income and expenditure to the correct funds of the charitable company. 8e¢8use of the inherent limttations of an audit. there is a risk that will not detect all irregularitles, including those leading to 8 material misstatement in the financial statements or non-compliance wtth regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statement$, as we will be les$ likely to become aware of Instances of non<omplian¢e. The risk Is also greater regarding irregularities occurring due to fraud rather than error, as fraud Involves intentional concealment, forgery, Collusion, omission or misrepresentation. A further description of our responsibilrties for the audrt of the financial statements is located on the Financial Reporting Council's webslte at V•WW.frc.org.uklauditorsresponslbilities. This description forms part of our Report of the IndependentAuditors. 13-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Use of our report This report is made solely to the charitable companls members, as a body, in accordance with Chapter 3 of Part 18 of the Companies Act 2006. Our audrt work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an audrtors, report and for no other purpose. To the fullest e*(ent permitted by law, we do not accept or assume responsibilrty to anyone other than the charitable company and the charitable companys members as a body, for our audrt work, for this report, or for the opinions we have formed. Matthew Brachèr FCA (Senlor Statutory Audllor) lor and on behalf of Haines Watts (Western) Limited Chartered Accountants and Statutory Audrtors 8ath House 6-8 Bath Street Bristol BS16HL Date.. 14-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2023 Unrestricted Designated funds funds Total 2023 Total 2022 Noles Incom and endowments from: Donations. legacies and grants Charrtable activrties Investments Other income 49,540 1,110,804 6,381 112,606 3,429,665 37,981 162,146 178,656 4,540,469 3,927,796 44,362 9,533 7,537 Total income 1,166,725 3,580,252 4,746.977 4.123,522 nditure on: Charrtable activrties Expendrture of charitable activities 1,173,670 3,448,043 4,621.713 4,057,765 Net income for the yearl N•t Incomlng resource• 16,9451 132,209 12S,264 85,757 Other recognlsed galns and losses Other gains or losses Transfers beeen funds 11 (171 143.7801 (17) (224) 43,780 Net movement In fund$ 36,835 88,412 125,247 65,533 Fund balances at 1 January 2023 802,987 2,819,976 3,622,963 3,557,430 Fund balance• at 31 December 2023 839.822 2,908.388 3,748,210 3,622.963 The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derNe from continuing 8Ctlvities. The statement of financial acttvities also complies wlth the requlrements for an income and expenditure account undef the Companies Act 2006. 15-
Draft Financlal Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) BALANCE SHEET AS AT 31 DECEMBER 2023 2023 Total funds 2022 Total fund8 Unrestricted Designated fund• fund8 Notes Flxed assets Tangible assets Current assets Debtors Cash at bank and in hand 13 833 33.487 34.320 57,890 14 170,757 734,942 633,720 2,616,665 804,477 3.351,607 1.049,648 2,899,076 905,699 3.250,385 4.156,084 3.948,724 Creditors: amount• falling due wllhln one y•ar 15 188.710) 1375,484) (442,194) (383,651) Net current assets 838,989 2.874,901 3.713,890 3.565,073 Total assets less current Ilabllltle8 839,822 2,908,388 3.748,210 3,822,983 Income funds Designated funds Unrestncted lunds 2,908,388 839,822 2.819,976 802,987 3,748,210 3,622.963 The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2023, although ar) audit has been cartièd oul under section 144 of the ChaTrtie5 Act 2011. The trustees are responsible for ensuring that the charty keeps accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view ol the state of affairs of the company as at the end of the financial year and of rts incoming resources and application ol resources, including 6ts income and expenditure, for the financial year in accordance with the requirements of section5 394 and 395 and which othenNise comply with the requirements of the Companies Act 2DD6 Telating to financial statements, so frdr as applicable to the company. These financial statements have been Prepared in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved by the Trustees on . Professor T Bowen Trustee Company Reglstration No. 02229663
Draft Flnanclal Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2023 2023 2022 Notes Cash flows from opgrating •ctlviti Cash generated fromjlabsorbed by) operations 21 417,990 (210.164) Cash flows from inve•tlng a¢tivitie6 Purchase of tangible fixed assèts Interest re¢eNed (9.821) H.362 (50.045) 9.533 Net cash gènerated froml(used in) Investlng actlvili•• 34.541 140,5121 Net IncrèaBeqdecrease) In ¢•sh and ca•h equivalents 452,531 1250,676) Cash and cash equivalents at beginning of year 2,899,076 3,149,752 Cash and ca•h equivalents at end of year 3,351,607 2,899.076 Notes to the Cash Flow Statement 1. Analysis of changes in net debt At 01101123 Cash flow At 31112r23 Nel cash Cash at bank and In hand 2,899,078 452,531 3.351,607 Total 2.899,078 452.531 3,351,607 17-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Accounting policies Charity Inlormation The Renal Associalion is a private company limited by guarantee incorporated in England and Wales. The registered office is Brandon House Building 20a1. Southmead Road, Bristol, BS34 7RR. 1.1 Accounting convention The financial ststements of the charitable company, which is a public benefit entity under FRS102, have beèn prepared In accordance with the Charities SORP {FRS 102) 'Accounting and Reporting by Chanties., Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 102) (effective 1 January 2019),, Financial Repo.n9 Standard 102 'The Financial Reports'ng Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The financial statements are prepared in Sterling. which is the functional currency of the Renal Association. Monetary amounts in these financial statements are rounded to the nearest £. The financial statements have been prepared under the historical cost convention.The principal accounting policles adopted are set out below. 1.2 Golng concern The accounts have been prepared on the assumption that the charitable company is able to continue as going concern. The charitable company holds unrestricted, general reserves of £839,822, designated reseNes that can be drawn down if necessary of £2,908,388 and a cash balance of £3,351,607. The trustees consider that the charitable company has sufficient eash reseNes to continue as a going concern for a period of at least 12 months trom the date on which these financial statements are approved. 1.3 Charltable funds Unreslrieted funds are used in accordance with the charitable objectives at the discretion of the trustees. Certaln fvnds will be designated for specific purposès. The Exe¢utive Committee have decided that setting aside funds in thls way is a useful financial dlscipline which will help the charity make the besl use of rts resources, even though there is no legal force to the designation Restricts'ons arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation ofthe nature and purpose of each fund is included In note 16 (movement in funds). 1.4 Income All income is recognised in the Statement of Financial Activities once the chanty ha5 enlitlernent to the funds, it is probable that the income will be received and the amount can be measured reliably. Full provision is made for subscriptions received in advance. All voluntary income is included in income on receipt basis. Tumover is measured al the fair value of the consideration received or receivable and represents amounts receivable for goods and services provided in the normal course of business. net of discounts, VAT and other sales related taxes. Caprtation fees and grants are recognised on a receivable basis. Scientific meetings are recognised on a receipt basis when tickets for a cOue or event are purchased. 18-
Draft Financial Statements at 13 May 2024 at 13:18".06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Accounting pollcles (Continuedy 1.5 Expenditure Liabilrties are recognised as expenditure as soon as there is a legal or constnjctive obligation commrtting the charity to that expenditure, rt is probable that a transfer of economic benef¢ts will be required in settlement and the amount of the obligation Can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under heading5 that aggregate all cosl rfrlated to the category. vJhere costs cannot be directly attributed to particular headings they have been alloceled to activrties on a basis consistent with the use of resources. Grants offered subject to condrtions which have not been met at the year end date are noted as commrtment but not accrued as expendrture. 1.6 Tangible Ilxed assets Tangible ed assets ar8 Inrtially measured at cost and subsequently measured at cost or valuats"on, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the followlng b8ses- Computer equipment Fixtures and fith'ngs 33% on cost 25% on cost Flxed assets are caprtalised when the initial cost exceeds £500. 1.7 Financial instruments The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments, and Section 12 'OtheT Financial Instruments Issues, of FRS 102 to all of rts financial instruments, Financial instruments are recognised when the charity becomes party to the contractual provisions of the instrument. Financial assets and liabilities are oftset, wrth the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Baslc flnanclal •Mets Basic financial assets, which include trade and other debtors and cash and bank balances. are initially measufed at transaction price including transaction costs and are subsequently carTied at amoth'sed cost Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the charty transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in rts entirety to an unrelated third paty. 8aslc financial liabilities Basic financial liabilities, including trade and other creditors are initially recognised at transaction price unle5$ the arrangement constrtutes a financing transaction. where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effectwe interest rate method. Financial liabilities are derecognised when. and only when, the charty's contractual obligatsons a discharged, cancelled, or they expire. 1.8 Taxation The chanty is exempt from corporation tax on its charitable activrties. 19-
Draft Financial Statements at 13 May 2024 at 13".18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Accounting policies (Contlnued) 1.9 Employw benefits The cost of any unused holiday entitlement is recognised in the period in which the employee's seNices are receNed. 1.10 Retiremont beneflt8 Payments to defined contribution retirement benefft schemes are charged as an expense as they fall due. 1.11 Lea8è8 Rentals payable and recewable under operating leases are charges to the SOFA on a straight line basis over the period of the lease. 1.12 Forelgn exchange Transactions in Cuene1eS other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetsry assets and liabilities that arè denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in net incomellexpenditurel for the period. Donatlon•, l•gacle• and grants Unrestricted Designated funds funds Total 2023 Total 2022 Grants Donations 45,415 4,125 112,606 158.021 4.125 175,770 2,886 49,540 112,606 162,148 178,656 Grants received, included In the above are as follows.. 2023 2022 Renal Association Unrestrictèd Renal Regi$try Designated 45.415 112.606 38,882 138,888 158,021 175,770 -20-
Or•ft Fln•ncll Stit•m•nt• at 13 M•y 2024 1113.'18..06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 1ft¢om• fmm ¢h•rft•bl• •ctlvlti C4plt41k)n f••• 3ubierlplloni -R•h•l 3¢1gTrtllkOlh•i Inc¢-01b•r lThcorn•- M••tlngi- R•n•lR•n•l R•ql•lry RM•l A•locl oolillon Totsl 2029 T)t•l 18w 41 18••mot•41 In¢ctm Irom ch•rtt•ble 4ctfvl•B 2,399,401 163,832 383,5 583,087 1,030,284 4,340,489 3,927,798 ATh•1 by lund Unritri¢ied lund* Dèjlgnatèd fundi 163,832 383,905 583,087 1,110,804 1,030,264 5.429.865 2.399,401 2,399,401 183,832 383.908 se3,Cé7 1,030,264 4,540,469 For tlw y••r •nd•d 31 O•¢•mb•r 1022 Unreslrlctod fundi 0•11gn•i•d lund¥ 177,484 223,418 438.484 839,386 3.089,410 2,107,440 890,970 2,197,410 177,464 223,418 439,484 890,97Q 3,927.79e 21
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Other charitable actlvlty income Unrestricted Deslgnated funds funds Total Total 2023 2023 2023 2022 Events Cross charge Project fees Other income 473,651 473,651 237.759 201,864 880,057 354,638 251,470 65,732 857.614 237,759 201,864 590,641 89,416 other income 563,067 1,030,264 1,593,331 1,329,454 Inve8trnent8 Unrestrlcted Designated funds funds Total 2023 Total 2022 Interest recelvable 6,381 37,981 44,382 9,533 Charitable activitles costs Direct costs Grant fijnding Support costs ol activities (See note 8) (See note 71 Totals Expenditure of Charitable activrties 624,722 39,703 3,957,288 4,621,713 Grants payable The total grants pard to individuals during the year was as follows.. 2023 2022 IndNidual grants 39,703 69,987 -22-
Oraft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Support Costs Management Finance Information technology Expenditure of Charitable activities 2,586.955 1.713 211,232 Human cources Other Governance costs Expenditijre of Charitable activities 141,069 160,742 855,577 Total Expenditure of Charitable activities 3.957.288 Support costs, included in the above, are as follows.. Managernent 2023 2022 Trustees. expenses Wages Social securty Pensions Training and Development 1,628 2,228,380 188.297 113,196 55,474 877 1,898,675 190,578 101,045 86,132 2,586,955 2,277,305 Flnance 2023 2022 Bank charges 1,713 1,413 Infomation teehnology 2023 2022 Computer,storage & advertising 211,232 364,602 -23-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 Support Costs (Contlnued) Human rèsources 2023 2022 Travelling & Subsistence 141,069 86,104 other 2023 2022 Offi¢e Costs Postage and stationery Depreciation of tsngible fixed assets Bad debt 113,993 6,380 33,391 6,978 132,202 5,059 27,465 (461) 160.742 164,265 Governance costs 2023 2022 Auditors, remuneration Legal and professional Secretarial fees Accountancy and legal 6.300 614,781 222,769 11.727 5,900 520,670 282,845 8,813 855,577 818,228 Tru•t•e8' remuneratlon and benefits Trustees expenses are paid wrth accordance to The Renal Association expense claim policy. In 2023 4 trustees were reimbursed expenses totaling £1.62812022.' £877 reimbursed to 3 trustees). 10 Employees The average monthly number employees during the year Wds". 2023 Number 2022 Number 44 42 -24-
Draft Flnancial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 10 Employee8 (Continued) Employment costs 2023 2022 Wages and salaries Social security Costs Other pension costs 2,228,360 188,297 113,196 1.898,675 190,576 101,045 2,529,853 2,190,296 The number of employee5 whose annual remunèration was more than £80,01)O is as follows: 2023 Number 2022 Number Employees earning over £60,000 11 Other gain8 or108se$ 2023 2022 Foreign exchange losses 17 224 -25-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 12 STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2022 Unrestrlcted Deslgnated funds funds Total funds Income from: Donations and legacies Charrtable activff(ies Investments Other income 41,768 839,386 137 7.537 136,888 3,088,410 9,396 178.656 3.927,796 9,533 7,537 Total income 888.828 3.234,694 4,123,522 ndlture on: Charitable actlvitles Expendrture of Charitable activitia$ Other recognlsed gains and losses Transfers beeenS funds 832,833 3,224,932 (224) 81,304 4,057,765 1224) (81.304) Net Incomel(Expendlture) (25.3091 90,842 65,533 Reconcillation of fund8 Total lund$ brought forward 828.298 2, 729,134 3,557,430 Totsl funds Carried forward 802.987 2,819,976 3,622,963 13 Tangible fixed assets Computer Flxtures and •qulpmenl litting• T¢)tal Cost At 1 January 2023 Additions 148,537 9,821 59,454 207,991 9.821 At 31 December 2023 158, 358 59,454 217.812 Depreciation and impairment At 1 January 2023 Depreciation charged in the year 102,372 21,666 47,729 11,725 150.101 33,391 At 31 December 2023 124,038 59,454 183,492 Carrying amount At 31 December 2023 34,320 34,320 At 31 December 2022 46.165 11.725 57,890 -26-
Draft Financlal Statements at 13 May 2024 at 13:18".06 THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 14 Debtor$ 2023 2022 Amounts falling due within one year: Trade debtors Purchase ledger debit balances Other debtor5 Prepayments and accrued income 369.761 153.528 7,854 273,334 560.527 160,722 5,447 322.952 804.477 1,049,648 15 Credllors: amounts falling due withln one year 2023 2022 othér taxation and social sècurity Trade creditors Other creditors Accruals and deferred income 58,121 64,476 40,027 279,570 60,069 79,124 48,306 196.152 442,194 383,651 -27-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 16 Movement In funds At 01101123 Net movement At 31112r23 in funds Unrestricted fvnds Rènal Association 802,987 36.835 839,822 Designated funds Renal Reglstry 2,819,976 88,412 2,908,388 Total i)Jnds 3,622,963 125,247 3.748,210 Net movemenl in funds, included in the above are as follows.. Incorning resources Resources expended Transfers Movement in funds Unre•trlct•d funds Renal Association 1,166,725 (1,173,670) 43,780 36,835 Designated fund8 Renal Registry 3,580.252 (3,448,060) (43.7801 88,412 Total funds 4,746.977 {4,621, 730) 125,247 0•8lgnated Fund• Brought forward Incoming resources Resources expended Carried Fopward Transfers Renal Reg15ty Deslgnated 2,819,978 3,580.252 (3.448,060) 143.7801 2.908,388 Total Deslgnated Funds 2,819.978 3,580.252 (3,448.060) (43,780) 2.908,388 Funds Renal ASslatIon Fund This lund Presents the free reseNes of the Charity. Renal Registry Fund This fund represents amounts which are commrtted to the UK Renal Registry and have been set aside by the Executive Committee to help the charity make best use of its resources. Transfer of Funds During the year there a transfer of £43,780 between unrestricted and designated funds. This related to the transfer of the accountancy costs and the interest received in the investments bank. -28-
Draft Financial Statements at 13 May 2024 at 13:18:06 THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (ACOMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 17 Share capital The charrtable company is limited by guarantee and therefore has no share capital. Each memberfs guarantee is limited to £1. 18 Relirement benefit schemes Defined ¢ontributlon schemes The chartty operates a defined contribution pension schemé for all qualifying employees. The assets of the scheme are held separately from those ofthé charity in an independently administered fijnd. Th8 charge to profft or loss in respect of defined contribution schemes was £113,19612022 .' £101,045). At the year end there were pensions of £15.400 {2022.' £14,934) deducted from salaries but not yet paid over to the pension scheme administrator. 19 Operating lease commitments The following oper8kn.ng lease payments are commltted to be paid 8$ follows.. Land and buildlngs 2023 2022 Within one year Between Nvo and five years In over fve years 48,600 192,000 38,800 48,600 192,000 87,400 279,400 328.000 20 Related party transactions During the year. the UK Kidney Association was paid by ANN UK £150, a related pafty due to the shared directors Helen Hurst and Karen Jenkins. Remunerallon of key management personnel The remunefatlon of key man8gèment personnel Is as foll*)WS. 2023 2022 Aggregate compensation 268,914 254,958 -29-
Draft Financial SLltennts at 13 May 2024 at 13:18:06 THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 21 Cash generated from operations 2023 2022 Surplus ft>r the year 125,264 65.757 Adjustments for. Investment income recognised in statement of financial activities Foreign exchange drfl8rences Depreciation and impairment of tangible fixed assets (44.362) (17) 33.391 (9.533) {224) 27,465 Movements in worklng capital.. Oecreasel(increase) in debtors Increasel(decreasel in credrtors 245.171 58,543 (252,452) (41,177) Cash generated froml(absorbed by) operatlon• 417,990 (210,184) -30-